XML 38 R27.htm IDEA: XBRL DOCUMENT v3.22.4
Stock-Based Compensation (Tables)
9 Months Ended
Jan. 31, 2023
Share-Based Payment Arrangement [Abstract]  
Summary of Stock Option Activity
A summary of the Company’s option activity during the nine months ended January 31, 2023 is as follows:
Options Outstanding
Number of
Stock Options
Outstanding
Weighted
Average
Exercise
Price
Weighted
Average
Remaining
Contractual
Life (years)
Aggregate
Intrinsic
Value
(in thousands)(in thousands)
Balance as of April 30, 202236,338 $12.44 7.34$165,436 
Options granted511 13.74 
Options exercised(758)15.39 
Options cancelled(513)12.95 
Balance as of January 31, 202335,578 $12.64 6.68$256,517 
Vested and exercisable as of January 31, 202320,944 $8.44 6.05$238,967 
Vested and expected to vest as of January 31, 2023(1)
35,774 $12.64 6.68$257,927 
__________________
(1)     The number of options vested and expected to vest as of January 31, 2023 includes early exercised, unvested Class A common stock. Refer to Note 7. Stockholders’ Equity for more information.
Schedule of Valuation Assumptions The weighted average assumptions underlying the fair value estimation are provided in the following table:
Nine Months Ended January 31,
20232022
Valuation assumptions:
Expected dividend yield— %— %
Expected volatility46.2 %43.5 %
Expected term (years)6.56.5
Risk-free interest rate3.8 %1.4 %
Schedule of Restricted Stock Unit Activity
A summary of the Company’s RSU activity during the nine months ended January 31, 2023 is as follows:
RSUs Outstanding
Number of RSUsWeighted Average
Grant Date Fair Value
Per Share
(in thousands)
Unvested Balance as of April 30, 202212,109 $36.04 
RSUs granted16,016 15.72 
RSUs vested(5,373)29.08 
RSUs forfeited(2,833)33.88 
Unvested Balance as of January 31, 202319,919 $21.89 
Schedule of Valuation Assumptions
The following assumptions were used to calculate the fair value of shares to be granted under the 2020 ESPP during the period:
Nine Months Ended January 31,
2023
Valuation assumptions:
Expected dividend yield— %
Expected volatility
47.8 - 61.4%
Expected term (years)
0.4 - 1.9
Risk-free interest rate
4.3 - 4.5%
Summary of Effects of Stock-Based Compensation
The following table summarizes the effects of stock-based compensation on the Company’s condensed consolidated statements of operations (in thousands):
Three Months Ended January 31,Nine Months Ended January 31,
2023202220232022
Cost of subscription$5,996 $2,639 $15,754 $5,824 
Cost of professional services361 704 1,911 1,991 
Sales and marketing18,316 8,850 54,175 28,540 
Research and development23,646 12,846 72,768 25,860 
General and administrative7,512 6,322 23,866 15,598 
Total stock-based compensation expense$55,831 $31,361 $168,474 $77,813